Home LiteratureArticle Details
PMID: 16528810 Published · ppublish English Comment Letter

Sildenafil citrate therapy for pulmonary arterial hypertension.

The New England journal of medicine ·Vol. 354 ·No. 10 ·2006-03-09 ·Pages 1091-3; author reply 1091-3

Kuschner WG

Abstract

暂无摘要

MeSH Terms
3',5'-Cyclic-GMP Phosphodiesterases/antagonists & inhibitors Humans Hypertension, Pulmonary/complications,drug therapy Patient Selection Phosphodiesterase Inhibitors/therapeutic use Piperazines/therapeutic use Pulmonary Disease, Chronic Obstructive/complications Purines Sildenafil Citrate Sulfones
Chemicals
Phosphodiesterase Inhibitors Piperazines Purines Sulfones Sildenafil Citrate 3',5'-Cyclic-GMP Phosphodiesterases
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Kuschner Ware G
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
Published
2006-03-09
Pages
1091-3; author reply 1091-3
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
PMID: 16291984
External Links
PubMed source View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2